The possible consequences of AFG3L2 mutation might be related to the pathophysiology of DOA, a disease which is caused by OPA1 haplo-insufficiency or eventually by a dominant negative process (Olichon et al., 2007). The gene discussed is AFG3L2; the disease is autosomal dominant optic atrophy.